Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34062
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18034/20233 (89%)
Visitors : 24008454      Online Users : 493
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34062


    Title: A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
    Authors: Li, Yi-Heng
    Chen, Jaw-Wen
    Lin, Tsung-Hsien
    Wang, Yu-Chen
    Wu, Chau-Chung
    Yeh, Hung-, I
    Huang, Chin-Chou
    Chang, Kuan-Cheng
    Wu, Cho-Kai
    Chen, Po-Wei
    Huang, Chen-Wei
    Chen, Zhih-Cherng
    Chang, Wei-Ting
    Huang, Wei-Chun
    Wang, Chih-Yuan
    Lee, Mei-Yueh
    Chao, A-Ching
    Fu, Wei-Ren
    Tsai, Li-Kai
    Tang, Sung-Chun
    Chan, Hsin-Lung
    Yang, Yi-Ching
    Wu, Yen-Wen
    Hwang, Juey-Jen
    Lin, Jiunn-Lee
    Contributors: Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Cardiol
    Natl Yang Ming Univ, Taipei Vet Gen Hosp & Inst Pharmacol, Dept Med Res & Educ
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp & Fac Med, Coll Med, Dept Internal Med,Div Cardiol
    China Med Univ, Asia Univ Hosp, Dept Internal Med, Div Cardiol,Coll Med & Hosp
    Natl Taiwan Univ, Div Cardiol, Dept Internal Med, Natl Taiwan Univ Hosp
    Natl Taiwan Univ, Grad Inst Med Educ & Bioeth, Coll Med
    Mackay Mem Hosp, Dept Internal Med & Med Res
    Mackay Med Coll, Dept Med
    Taipei Vet Gen Hosp, Dept Med Educ, Dept Med, Div Cardiol
    Natl Yang Ming Univ, Cardiovasc Res Ctr
    China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Cardiovasc Med
    China Med Univ, Coll Med
    Natl Taiwan Univ Hosp, Div Cardiol, Dept Internal Med
    Natl Taiwan Univ, Coll Med
    Chi Mei Med Ctr, Dept Internal Med, Div Cardiol
    Chia Nan Univ Pharm & Sci, Dept Pharm
    Kaohsiung Vet Gen Hosp, Dept Internal Med, Div Cardiol
    Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Endocrinol & Metab
    Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Fac Med
    Kaohsiung Med Univ Hosp, Dept Neurol
    Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med
    Kaohsiung Med Univ, Dept Neurol, Coll Med
    Mackay Mem Hosp, Dept Neurol
    Natl Taiwan Univ Hosp, Stroke Ctr & Dept Neurol
    Mackay Mem Hosp, Mackay Med Coll, Dept Family Med, Dept Med
    Natl Cheng Kung Univ, Dept Family Med, Natl Cheng Kung Univ Hosp, Coll Med
    ] Far Eastern Mem Hosp, Cardiovasc Med Ctr, Cardiol Div
    Natl Yang Ming Univ, Sch Med
    Natl Taiwan Univ Hosp, Cardiol Div, Dept Internal Med
    Natl Taiwan Univ Hosp Yun Lin, Dept Internal Med, Div Cardiol
    Taipei Med Univ, Dept Internal Med, Div Cardiovasc Med, Shuang Ho Hosp
    Keywords: Atherosclerosis
    Risk factors
    Performance guide
    Date: 2020
    Issue Date: 2022-11-18 11:22:19 (UTC+8)
    Publisher: Elsevier Taiwan
    Abstract: Atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease, cerebrovascular disease, and peripheral artery disease, carries a high morbidity and mortality. Risk factor control is especially important for patients with ASCVD to reduce recurrent cardiovascular events. Clinical guidelines have been developed by the Taiwan Society of Cardiology, Taiwan Society of Lipids and Atherosclerosis, and Diabetes Association of Republic of China (Taiwan) to assist health care professionals in Taiwan about the control of hypertension, hypercholesterolemia and diabetes mellitus. This article is to highlight the recommendations about blood pressure, cholesterol, and sugar control for ASCVD. Some medications that are beneficial for ASCVD were also reviewed. We hope the clinical outcomes of ASCVD can be improved in Taiwan through the implementation of these recommendations. Copyright (C) 2019, Formosan Medical Association. Published by Elsevier Taiwan LLC.
    Relation: Journal of The Formosan Medical Association, v.119, n.3, pp.11
    Appears in Collections:[Dept. of Biotechnology (including master's program)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    10.1016j.jfma.2019.04.007.pdf393KbAdobe PDF90View/Open
    index.html0KbHTML381View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback